Novartis Pharmaceuticals Corp. recalls SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only, Manufactured by: DELPHARM
Recalled September 27, 2023 · FDA recall D-1174-2023 · Novartis Pharmaceuticals
Hazard
Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals. · FDA Class I
Units
1272 bottles
Sold at
Nationwide in the USA
Description
Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals.
Product
SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only, Manufactured by: DELPHARM Huningue S.A.S., Huningue, France, Distributed by: Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936, NDC 0078-0110-22.
Manufacturer(s)
Novartis Pharmaceuticals Corp.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →